Germany orders 3 million euros of cannabis from Tilray Portugal

The Canadian company, which opened its medical cannabis production plant in Cantanhede in the Coimbra district this year, and recently leased 20 hectares of production land in Reguengos de Monsaraz, near Évora, has signed an initial supply contract of 3.3 million dollars (approximately three million euros) with Cannamedical Pharma to increase the distribution of medical cannabis products to German patients.

The export operation is expected to be carried out in the autumn, being "the first of its kind that Tilray will conduct from its Portugal facility to supply patients in Germany," the company explained.


Tilray signs first deal to supply pot to Europe out of new Portugal facility

Tilray Inc. has signed its first agreement to supply a European Union country with cannabis from its recently opened facility in Portugal, the company announced early Wednesday morning.

The freshly inked contract with Cannamedical Pharma GmbH to export $3.3 million worth of cannabis to medical patients in Germany gives Tilray TLRY, +3.45%  access to a country with a population and gross domestic product that are twice the size of its home country, Canada. The deal also marks another step for Tilray and its global ambitions, Chief Executive Brendan Kennedy said in a telephone interview.


Tilray® increases international export capacity with new outdoor cultivation site in Portugal

Tilray, Inc. (“Tilray” or “the Company”) (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced that its wholly-owned subsidiary Tilray Portugal Unipessoal Lda.


Flowr Ships clones to support start-up of operations in Portugal

The Flowr Corporation (TSXV: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) is pleased to announce that Holigen Holdings Limited (“Holigen”), which Flowr is in the process of acquiring the remaining 80.2% interest, subject to regulatory approval, has through its subsidiary RPK Biopharma, Unipessoal Lda, received permission from INFARMED to plant cannabis at the Aljustrel project in Portugal.


Tilray speeds expansion in Europe

Tilray Inc. is expanding its European leadership team and setting up a hub in Portugal, deepening its planned international reach.

The company appointed five senior members to its European team, according to a statement Friday. Arne Wilkens, a former executive at the German pharmaceuticals company AiCuris, will take on the role of vice president of business expansion in Europe.


Hemp farmers in Portugal say 2019 growing season is lost

Some Portuguese hemp farmers say they’ll give up on the 2019 growing season due to continuing jurisdictional confusion between two government agencies over licensing.

The problem started when Portugal’s Ministry of Agriculture issued a clarification in January 2019 making all hemp related authorizations subject to review by INFARMED, the Portuguese Health Regulator that has authority over pharmaceutical products and controlled substances.


A brief history of CBD

CBD – short for Cannabidiol – is a compound inside hemp and cannabis that was first discovered in 1940. Recent studies have shown CBD to have medicinal value for treating things like anxiety, pain, and insomnia but where did the story begin with this gift from nature?


Portugal: €45M investment in medical marijuana production

Holigen have announced plans to invest €45 million in the production of medical marijuana in Portugal over the next four years.

Pauric Duffy from Holigen told Lusa News Agency that he expects the investment will lead to the creation of some 200 jobs.

"We received our production license this year and we are building our facilities in Sintra (21,500 square metres) and Aljustrel (7,000,000 square metres). If the entire licensing process goes as planned, in the third quarter of 2019 we will be fully operational in Sintra and, in 2020, in Aljustrel”, said Duffy.


Sunny Portugal now path to EU medical marijuana

For years, the Portuguese city of Cantanhede has been known for its wine products and roasted suckling pig, a local specialty. But the city has something new: Portugal’s first medical cannabis production farm.

The cannabis plant produces cannabinoids – chemical compounds used in treating health disorders. Parts of the plant are used to make the drug marijuana as well as a number of products containing the compounds CBD and THC.

Portugal’s sunny weather is ideal for growing cannabis. The weather caught the attention of Brendan Kennedy. He is Chief Executive Officer of the Canadian company Tilray, one of the world’s largest producers of medical cannabis.


Sunny Portugal: A gateway to Europe's medical pot market

Famous for its roasted suckling pig and wines, the Portuguese city of Cantanhede now hosts the country's first medical cannabis production farm - a budding European hub of efforts to meet growing demand for the flowering herb.

Portugal's California-like weather caught the eye of Canada-based Tilray as its CEO Brendan Kennedy roved around Europe from 2015 to 2017 in search of the perfect spot for a new production site.

Kennedy said Portugal had the ideal climate for cannabis cultivation and the country's young, educated workforce and its major agricultural sector were further attractions.


Subscribe to RSS - Portugal